Kenvue Inc. (KVUE)
Sector: Basic Materials
Industry: Perfumes, Cosmetics & Other Toilet Preparations
Country: United States
Exchange: NYSE
Market cap: $34.32B
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Latest financial period: June 28, 2026
Filed with the SEC: August 6, 2026
Estimated earnings date: November 2, 2026
Profit #700 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 10.4% | 9.7% | 9.2% | 9.0% |
Growth #1153 of 1484 companies
Payout #676 of 1484 companies
Safety #205 of 1484 companies
Price #491 of 1484 companies
